Merck & Co., Inc. Release: Exubera Effective In Diabetes Patients Who Have Respiratory Infections Or Are Exposed To Passive Cigarette Smoke, New Analyses Show

COPENHAGEN, Denmark, Sept. 14 /PRNewswire-FirstCall/ -- Adult patients with diabetes who took Exubera® (insulin human [rDNA origin]) inhalation powder were able to safely maintain good blood sugar control even if they developed a respiratory infection or were exposed to passive (second-hand) cigarette smoke. These analyses were presented today at the 42nd European Association for the Study of Diabetes.